Back to ACRS

MARSHALL WACE, LLP → ACRS

MARSHALL WACE, LLP ACRS Position History

Aclaris Therapeutics, Inc. • Healthcare

Quarters held
15
Latest value
$3.1M
Q3 2026
Peak value
$5M
First seen
Q2 2023

Dollar value over time

Show data table
PeriodPosition value
Q2 2023$315K
Q4 2024$1.5M
Q4 2024$5M
Q1 2025$1M
Q1 2025$2.5M
Q2 2025$943K
Q2 2025$2.3M
Q3 2025$1M
Q3 2025$2.2M
Q4 2025$83K
Q4 2025$1.4M
Q1 2026$46K
Q1 2026$2.6M
Q3 2026$223K
Q3 2026$3.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$3.1M588.5K——
Q3 2026$223K42.3K——
Q1 2026$2.6M700.7K——
Q1 2026$46K12.3K——
Q4 2025$1.4M458.1K——
Q4 2025$83K27.4K——
Q3 2025$2.2M1.17M——
Q3 2025$1M544.0K——
Q2 2025$2.3M1.63M——
Q2 2025$943K664.3K——
Q1 2025$2.5M1.66M——
Q1 2025$1M654.2K——
Q4 2024$5M2.02M——
Q4 2024$1.5M617.6K——
Q2 2023$315K30.4K——

Other funds holding ACRS

Other MARSHALL WACE, LLP positions

ETHA

ISHARES-S&P 500

$17B
IAU

ISHARES-S&P 500

$12B
ETHA

ISHARES-S&P 500

$11.5B
IAU

ISHARES-S&P 500

$11.1B
IAU

ISHARES-S&P 500

$10.7B
IAU

ISHARES-S&P 500

$10.3B
IAU

ISHARES-S&P 500

$9.9B
ETHA

ISHARES-S&P 500

$8.4B